Anti-Diabetic Medications to Fight PD and LBD

Completed · Phase 4 · Has a placebo group

Conditions studied: Lewy Body Dementia, Parkinson Disease

In brief

The purpose of this study is to test the hypothesis that DPP4 inhibitors and SGLT2 inhibitors are well tolerated and have beneficial neurological effects, specifically for Parkinson's disease and Lewy body dementia.

Key facts

Study ID
NCT06263673
Run by
Mayo Clinic
People needed
18
Starts
2024-05-07
Expected to finish
2025-01-08
Last updated by the study team
2026-01-28

Who can join

Age: 45 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.